Safety of Arthritis Drugs, Day 2, Part 1
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration… read more
Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close
People in this video
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
-
Hosting Organization
More Videos From
Safety of Arthritis Drugs, Day 2,
More VideosRelated Video
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…
-
FDA Oversight of Food Safety
Representative Timothy Murphy talked about today’s House Energy and Commerce hearing on the Salmonella outbreak, and he…
-
FDA Drug Approval Process
Catherine Larkin talked about the FDA’s drug approval and review processes for current drugs on the market. She…
-
Safety of Foreign-Made Prescription Drugs
Allan Coukell talked about the Governmental Accountability Office (GAO) report on the make-up of prescription drugs,…